Valuation: InterCure Ltd.

Market Cap 191M 0 166M 156M 142M 266M 18.32B 268M 1.87B 719M 9.3B 718M 702M 29.55B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 328M 0 284M 268M 243M 456M 31.39B 459M 3.2B 1.23B 15.93B 1.23B 1.2B 50.63B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+0.56%
1 week-2.76%
Current month-9.53%
1 month+15.27%
3 months+20.49%
6 months+29.43%
Current year+0.31%
1 week 1,593
Extreme 1593
1,702
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 66 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%-2.76%-38.07%-48.01% 63.09M
+2.60%-2.64%+11.74%+197.98% 352M
+3.12%-2.94%-36.81%-38.12% 146M
0.00%0.00%+17.75%+107.29% 142M
-1.96%+6.38%-18.03%-56.52% 104M
-50.00%0.00%-50.00%-85.71% 50.28M
Average -7.61%+16.40%-18.90%+12.82% 142.88M
Weighted average by Cap. -1.53%+4.83%-6.44%+77.16%

Financials

2024 2025
Net sales 239M 0 207M 195M 177M 332M 22.89B 335M 2.33B 899M 11.61B 897M 877M 36.92B 270M 0 234M 221M 200M 376M 25.9B 379M 2.64B 1.02B 13.14B 1.01B 992M 41.77B
Net income -67.8M -0 -58.74M -55.44M -50.29M -94.34M -6.5B -95.03M -662M -255M -3.3B -255M -249M -10.48B -35.71M -0 -30.94M -29.2M -26.49M -49.69M -3.42B -50.05M -349M -134M -1.74B -134M -131M -5.52B
Net Debt 133M 0 115M 109M 98.48M 185M 12.72B 186M 1.3B 500M 6.45B 499M 488M 20.52B 136M 0 118M 111M 101M 190M 13.07B 191M 1.33B 513M 6.63B 512M 501M 21.07B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-09-14 ILA 1,623.00 +0.56% 4,478
26-09-10 ILA 1,614.00 -1.41% 9,949
26-09-09 ILA 1,637.00 -2.79% 8,278
26-09-08 ILA 1,684.00 +0.90% 6,257
26-09-07 ILA 1,669.00 +0.42% 12,751
  1. Stock Market
  2. Stocks
  3. INCR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!